NeuroCME

This activity is expired and is no longer available for CME credit.

EXPERT INTERVIEWTEXT BASEDCME

Risk vs Benefit in Implementing Natalizumab

Author(s)/Faculty: Bruce A. Cohen, MD
Release Date: 4/9/2014Expiration Date: 4/8/2015
Credit Type: CMENumber of Credits: 0
Content Type: MonographProvider:
Dr. Bruce Cohen discusses the appropriate implementation and utilization of natalizumab in patients with MS.